According to the latest research, four out of 10 men die from prostate cancer. Oakwood University Church wants to inform and engage as many as…
From
To
A surgeon performs a robot-assisted prostate surgery on April 10, 2014 at the Edouard Herriot hospital in Lyon, France.
Novartis, picture here, is the maker of prostate cancer drug, Pluvicto, which is in such short supply.
Doctors across the United States who treat people with advanced prostate cancer can't find supplies of a medicine that may help them live longer.
A surgeon sitting in front of screens of a Focal One device performs a robot-assisted prostate tumorectomy using ultrasound imaging on April 1…
Most men who are diagnosed with prostate cancer can delay or avoid harsh treatments without harming their chances of survival, according to ne…
A prostate cancer screening is better than originally thought, especially for Black men, a study says.
A blood test to screen for prostate cancer may be better at doing so than experts originally thought, particularly among Black men, according …